{"title":"Fibrates: past history or renaissance?","authors":"Robert Elkeles","doi":"10.15277/bjd.2023.415","DOIUrl":null,"url":null,"abstract":"Fibrates have been in use to modify serum lipids since the 1960s. This review seeks to ascertain their present place in lipid-modifying therapy and prevention of cardiovascular disease, particularly in type 2 diabetes (T2DM).","PeriodicalId":42951,"journal":{"name":"British Journal of Diabetes","volume":" 4","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15277/bjd.2023.415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Fibrates have been in use to modify serum lipids since the 1960s. This review seeks to ascertain their present place in lipid-modifying therapy and prevention of cardiovascular disease, particularly in type 2 diabetes (T2DM).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
